CardieX Ltd (ASX:CDX) has launched the world’s first heart health monitoring smartwatch to feature ATCOR heart health technology through its commercial partnership with Mobvoi, a leading consumer electronics and enterprise AI developer.
The TicWatch GTH Pro is the world’s first consumer device to feature unique and proprietary heart health features powered by CardieX subsidiary, ATCOR.
ATCOR’s proprietary Arty™ Heart Health analytics platform is an advanced heart and arterial health management platform based on ATCOR’s FDA-cleared SphygmoCor® technology.
The TicWatch GTH Pro was launched on March 1, 2022, via Mobvoi.com, Amazon and GTHPro.com for customers in the United States.
Australians and New Zealanders can pre-order the watch on Amazon and Mobvoi.com.
Core watch features
It has taken two years of co-development between Mobvoi and CardieX to develop the new consumer smartwatch, with hardware and firmware development led by Mobvoi and focused on the integration of a unique set of ‘Arty Heart Health’ algorithms that give users deep insights into their arterial and overall heart health.
‘Arty Heart Health powered by ATCOR’ non-invasively measures 'central arterial waveforms', which are pressure waves based on the strength of the pulse as blood flows through the body.
The TicWatch GTH Pro utilises unique 'dual PPG sensors' to provide insights into arterial health through high-fidelity sensing points that track both from the wrist and by way of a special PPG finger sensor.
Data gathered from the watch appears on the Mobvoi app and the Arty Heart Health platform compiles the metrics into five key points of heart health analysis. Combined with Mobvoi’s own smartwatch metrics, the Arty Heart Health platform gives users easy-to-understand insights into their overall wellness and cardiovascular health. The Arty Heart Health platform includes:
- Arty Score – a general score on overall heart and arterial health.
- eCAP™ (Exercise Capacity™) – which is a measure of healthy blood flow to the heart muscles.
- ArtyAge™ – an estimated 'age' of the arteries based on arterial stiffness.
- HSX™ (Heart Stress Index) – a measure of stress on the heart; and
- TruHR™ – a highly accurate medical grade1 heart rate measurement similar to an electrocardiogram. All the above parameters are based upon ATCOR’s FDA-cleared SphygmoCor® technology.
Heart health insights battle disease
“I am excited to finally announce the official launch and availability of the TicWatch GTH Pro. This is the first integration of our market leading SphygmoCor® heart health technology into a wearable device and has been the result of a significant two-year collaboration with Mobvoi,” CardieX CEO and managing director Craig Cooper said.
“Our ‘Arty Heart Health’ platform incorporates unique arterial biometrics and heart health insights based on the 20-year legacy of our ATCOR subsidiary in partnering with global research organizations, pharmaceutical companies and leading clinical practices. It’s this same trusted, clinical grade technology that we are now incorporating into a series of new consumer wearables and home health devices.
“Cardiovascular disease remains the world’s number one killer. It’s our vision and mission to provide advanced heart health metrics into the hands of consumers so that they may have better tools and insights to manage and prevent disease.
“Ultimately, the more accurate the data you have, the more informed you are to make decisions about your health. The TicWatch GTH Pro is the first in a number of new consumer product releases planned for this year as we continue to move forward with the development, FDA clearance process and launch of a suite of new wearable and home health devices and apps under our new CONNEQT brand.”
Heart health a top issue
"With the decrease of health that we saw in the past two years from the pandemic, heart health remains a top issue for healthcare providers," Mobvoi vice president Carol Wu said.
"Partnering with CardieX to introduce state-of-the-art heart health monitoring technology to our line of TicWatches is one way to achieve our mission of providing innovative and modern ways to track health and look good doing it."